U.S. National Institutes of Health
U.S. National Institutes of Health

IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
4869148691Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or DecitabineActive, not recruitingNo Results AvailableMyelodysplastic Syndromes|Refractory Anemia With Excess Blasts|Chronic Myelomonocytic Leukemia|CytopeniaDrug: rigosertib sodiumhttps://ClinicalTrials.gov/show/NCT01928537
4869248692Chemotherapy for Patients With Cancer of the StomachRecruitingNo Results AvailableFirst-line Treatment for Patients With Non-resectable Gastric Cancer or Cancer of the Esophagus orDrug: DOS2W|Drug: DOS3Whttps://ClinicalTrials.gov/show/NCT01928524
4869348693Efficacy of Switching or Adding Pegylated Interferon in Chronic Hepatitis B Patients on Long Term Oral Antiviral TherapyRecruitingNo Results AvailableChronic Hepatitis BDrug: peg-interferon alpha 2b, 1.5mcg/kg s/c given weekly|Drug: Nucleos(t)ide analogue therapyhttps://ClinicalTrials.gov/show/NCT01928511
4869448694Drug Eluting Balloon for Prevention of Hemodialysis Access RestenosisNot yet recruitingNo Results AvailableArteriovenous Fistulae|Arteriovenous GraftDevice: Paclitaxel Eluting Balloon Angioplasty|Device: Percutaneous Transluminal Angioplasty (PTA)https://ClinicalTrials.gov/show/NCT01928498
4869548695Green Tea Extract in Treating Patients With Low-Risk Prostate CancerRecruitingNo Results AvailableStage I Prostate Cancer|Stage IIA Prostate Cancer|Stage IIB Prostate CancerOther: active surveillance|Drug: Sunphenon|Other: laboratory biomarker analysis|Other: Questionnaire Administrationhttps://ClinicalTrials.gov/show/NCT01928485
4869648696Dose-finding Study of Four Dosage Levels of an H7N9 Influenza Vaccine in Adults Between Ages of 18 Years and 65 YearsCompletedHas ResultsH7N9 InfluenzaBiological: H7N9c low dose with adjuvant|Biological: H7N9c medium dose with adjuvant|Biological: H7N9c high dose with adjuvant|Biological: H7N9c high dose without adjuvanthttps://ClinicalTrials.gov/show/NCT01928472
4869748697Phase 1b Trial of BGJ398/BYL719 in Solid TumorsRecruitingNo Results AvailableAdvanced Solid Tumors,|Metastatic Solid TumorsDrug: BGJ398|Drug: BYL719https://ClinicalTrials.gov/show/NCT01928459
4869848698Lithium for Suicidal Behavior in Mood DisordersRecruitingNo Results AvailableDepressive Disorder|Bipolar Disorder|Suicide|Suicide, AttemptedDrug: Lithium|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01928446
4869948699Finafloxacin for the Treatment of cUTI and/or Acute PyelonephritisActive, not recruitingNo Results AvailableUrinary Tract Infections|Acute PyelonephritisDrug: Finafloxacin 800 mg i.v. once daily|Drug: Finafloxacin placebo i.v. once daily|Drug: Finafloxacin 800 mg tablets (as four 200 mg tablets) once daily|Drug: Finafloxacin placebo tablets (as four tablets) once daily|Drug: Ciprofloxacin 400 mg i.v. two times daily|Drug: Ciprofloxacin placebo i.v. two times daily|Drug: Ciprofloxacin 500 mg oral (as two 250 mg capsules) two times daily|Drug: Ciprofloxacin placebo oral (as two capsules each) two times dailyhttps://ClinicalTrials.gov/show/NCT01928433
4870048700A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's DiseaseRecruitingNo Results AvailableAlzheimer's Disease|DementiaDrug: Drug: NIC5-15|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01928420
4870148701Evaluation of the Efficacy and Safety Between Two Antiretroviral Regimens, in HIV-1-infected Treatment-naïve Subjects With Low CD4 CountsRecruitingNo Results AvailableHIV-1 Infection|Immunosuppression-related Infectious DiseaseDrug: DARUNAVIR|Drug: ATAZANAVIRhttps://ClinicalTrials.gov/show/NCT01928407
4870248702A Phase 1/2, Open-label Study of Nivolumab Monotherapy or Nivolumab Combined With Ipilimumab in Subjects With Advanced or Metastatic Solid TumorsRecruitingNo Results AvailableAdvanced or Metastatic Solid TumorsBiological: Nivolumab|Biological: Ipilimumabhttps://ClinicalTrials.gov/show/NCT01928394
4870348703Safety, Tolerability and Preliminary Efficacy of AZD5213 in Combination With Pregabalin in Subjects With PDN and Good Pain Reporting AbilityCompletedNo Results AvailableDiabetic Neuropathy, Painful; Diabetic NeuropathiesDrug: AZD5213 + pregabalin|Drug: Placebo|Drug: pregabalin capsuleshttps://ClinicalTrials.gov/show/NCT01928381
4870448704A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.RecruitingNo Results AvailableAsthmaDrug: AMG 282|Drug: AMG 282 Matching Placebohttps://ClinicalTrials.gov/show/NCT01928368
4870548705Cognitive Dysfunction in People Who Are Obese But Metabolically HealthyNot yet recruitingNo Results AvailableMetabolic Syndromehttps://ClinicalTrials.gov/show/NCT01928355
4870648706The Effects of Coenzyme A Combined With Statin on Serum Lipids in Patients With HyperlipidemiaRecruitingNo Results AvailableHyperlipoproteinemiaDrug: Coenzyme A|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01928342
4870748707A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I DiabetesRecruitingNo Results AvailableType I DiabetesDrug: Exenatide (Bydureon®)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01928329
4870848708A Bioequivalence Study of Domestic (Made in China) and Imported Mizolastine Tablets in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: Mizolastine domestic (made in China)|Drug: Mizolastine (imported)https://ClinicalTrials.gov/show/NCT01928316
4870948709Predicting Oxycodone Dose From Oral Fluid Drug LevelsCompletedNo Results AvailableChronic Painhttps://ClinicalTrials.gov/show/NCT01928303
4871048710Combination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal CancerRecruitingNo Results AvailableStomach Neoplasms|Esophageal NeoplasmsDrug: Irinotecan|Drug: Trastuzumab|Drug: Oxaliplatin|Drug: Leucovorin|Drug: Fluorouracilhttps://ClinicalTrials.gov/show/NCT01928290
4871148711Weaning From Mechanical Ventilation: Spontaneous Breathing Trial and the Assessment of Work of BreathingCompletedNo Results AvailableWeaning Failurehttps://ClinicalTrials.gov/show/NCT01928277
4871248712Physical Activity in Insurance Medicine: Effects on Patients With Psychiatric DisordersRecruitingNo Results AvailableDepressive Disorder|Somatoform Disorder|Anxiety Disorder|Personality DisorderBehavioral: Physical activityhttps://ClinicalTrials.gov/show/NCT01928264
4871348713Promoting Smoking Cessation in the Community Via Quit to Win Contest 2013CompletedNo Results AvailableSmoking CessationBehavioral: Informed early monetary incentive|Behavioral: Uninformed early monetary incentivehttps://ClinicalTrials.gov/show/NCT01928251
4871448714Physiologic Effects of Noninvasive Neurally Adjusted Ventilatory Assist (NAVA) Versus Noninvasive Pressure Support Ventilation in Patients at Risk for Respiratory Distress Needed Preventive Used of Noninvasive Ventilation After Extubation.CompletedNo Results AvailableAcute Respiratory DistressDevice: Noninvasive neurally adjusted ventilatory assist (NIV-NAVA).|Device: Noninvasive pressure support ventilation (NPSV)https://ClinicalTrials.gov/show/NCT01928238
4871548715Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSILEnrolling by invitationNo Results AvailableCervical High Grade Squamous Intraepithelial LesionBiological: Human Papillomavirus vaccinehttps://ClinicalTrials.gov/show/NCT01928225
4871648716Retinal Nerve Fiber Layer Thickness Changes in Parkinson Disease: A Meta-analysisCompletedNo Results AvailableParkinson DiseaseDevice: Optical coherence tomographyhttps://ClinicalTrials.gov/show/NCT01928212
4871748717Efficacy Study of Sitagliptin to Prevent New-onset Diabetes After Kidney TransplantRecruitingNo Results AvailablePosttransplant Diabetes MellitusDrug: Sitagliptin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01928199
4871848718FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast CancerRecruitingNo Results AvailableEstrogen Receptor Positive|HER2/Neu Negative|Male Breast Carcinoma|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage IIA Breast Cancer|Stage IIB Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast CancerDrug: Fluorothymidine F-18|Procedure: Positron Emission Tomography|Other: Laboratory Biomarker Analysishttps://ClinicalTrials.gov/show/NCT01928186
4871948719Self-Help Video for Insomnia in College StudentsSuspendedNo Results AvailableSleep Initiation and Maintenance DisordersBehavioral: Abbreviated cognitive behavioral therapy|Behavioral: Sleep education/sleep hygienehttps://ClinicalTrials.gov/show/NCT01928173
4872048720Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient With Stage IV Non-Small Cell Lung Cancer Resistant to First-Line Therapy With Erlotinib Hydrochloride or GefitinibWithdrawnNo Results AvailableRecurrent Non-small Cell Lung Cancer|Stage IV Non-small Cell Lung CancerDrug: pemetrexed disodium|Drug: carboplatin|Drug: cisplatin|Drug: erlotinib hydrochloride|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01928160

* Görseller ve İçerik tekif hakkına sahip olabilir